Pegmusirudin

DB19220InvestigationalProtein Based Therapies

Pegmusirudin is under investigation in clinical trial NCT00074620 (A Clinical Study to Assess the Safety of Peg-hirudin (SPP200) Compared to Heparin in Patients Who Are on Haemodialysis).

Also known as
PEG-Hirudin
Code names
SPP200

Resolves to

Clinical / RWD
Targets

What you can answer from here — as of April 23, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Pegmusirudin, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account